Jinhe Biotechnology CO., LTD.

002688

CNE100001HK7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
3.82 ^CNY	+0.79%		+6.70%	-20.58%

Apr. 03	Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on February 6, 2024.	CI
Feb. 05	Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares.	CI

Jinhe Biotechnology Co., Ltd. Announces Final Profit Distribution Proposal for 2022

April 24, 2023 at 03:48 pm EDT

Jinhe Biotechnology CO., LTD. announced on 24 April 2023 the final profit distribution proposal for 2022 as Cash dividend/10 shares (tax included): CNY 1.00000000.

Latest news about Jinhe Biotechnology CO., LTD.

Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on February 6, 2024.	Apr. 02	CI
Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares.	Feb. 05	CI
Jinhe Biotechnology CO., LTD. authorizes a Buyback Plan.	Feb. 04	CI
Jinhe Biotechnology Chairman Proposes Buyback of Up to 100 Million Yuan Shares	Feb. 02	MT
Jinhe Biotechnology Gets Nod for Live Brucellosis Vaccine	Nov. 10	MT
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023	23-05-30	CI
Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd.	23-05-24	CI
Jinhe Biotechnology CO., LTD. Announces Board Election	23-05-15	CI
Jinhe Biotechnology CO., LTD. Approves Cash Dividend (Tax Included) for 2022	23-05-15	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Jinhe Biotechnology Co., Ltd. Announces Final Profit Distribution Proposal for 2022	23-04-24	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022.	22-10-10	CI
Jinhe Biotechnology to Take Full Control of Environmental Protection Firm For $46 Million	22-09-12	MT
Jinhe Biotechnology CO., LTD. agreed to acquire 49% stake in Inner Mongolia Jinhe Environmental Protection Technology Co., Ltd. from and others for CNY 318 million.	22-09-09	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022.	22-07-01	CI
Jinhe Biotechnology CO., LTD. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 12, 2022.	22-05-25	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-21	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Jinhe Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-23	CI
Jinhe Biotechnology CO., LTD. announced that it has received CNY 819.999998 million in funding from a group of investors	21-07-25	CI

Chart Jinhe Biotechnology CO., LTD.

Duration

Period

More charts

Jinhe Biotechnology CO., LTD. is a China-based company principally engaged in the research, development, production and sale of pharmaceutical feed additives. The Company's main products include animal feed additives, veterinary drug additives, veterinary vaccines and veterinary drugs. The Company is also involved in processing of corn starch, as well as wastewater treatment business. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
JINHE BIOTECHNOLOGY CO., LTD.	-20.58%	397M
ZOETIS INC.	-19.73%	72.39B
ELANCO ANIMAL HEALTH INCORPORATED	-11.01%	6.54B
BLUESTAR ADISSEO COMPANY	+15.88%	3.43B
VIMIAN GROUP AB	-0.68%	1.4B
JINYU BIO-TECHNOLOGY CO., LTD.	-17.27%	1.34B
VETOQUINOL SA	-2.73%	1.26B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-28.16%	1.2B
WUHAN KEQIAN BIOLOGY CO.,LTD	-14.67%	1.12B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-5.37%	990M

Veterinary Drugs